Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.69
-0.05-2.87%
At close: -
$1.69
-0.000100-0.01%
After Hours: 7:25 PM EDT
Comments
Loading...
Immuneering (IMRX) Forecast
NewsEarningsImmuneering (IMRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Immuneering Stock Price, Quotes and Forecasts | NASDAQ:IMRX | Benzinga
Explore Immuneering stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IMRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Who are Immuneering (IMRX) competitors?
Other companies in Immuneering’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX), Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR) and PepGen (NASDAQ:PEPG).
What is the forecast, or price target, for Immuneering (IMRX) stock?
Immuneering has a consensus price target of $14.67.
What is the current price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $1.6899 last updated March 25, 2025 at 7:25 PM EDT.
Does Immuneering (IMRX) pay a dividend?
There are no upcoming dividends for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.